2003
DOI: 10.1016/j.humimm.2003.08.201
|View full text |Cite
|
Sign up to set email alerts
|

Accurate, rapid charaterization of HLA-specific antibody using luminex technology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0
2

Year Published

2004
2004
2012
2012

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 0 publications
0
5
0
2
Order By: Relevance
“…In the present study, we have directly compared two solid phase assays for the detection of antibodies. Previous reports have suggested the Luminex assay detects HSA more frequently than the ELISA assay (34,35). We have shown that both class I and class II antibodies are detected more frequently by Luminex, although the difference in frequency was only significant for class I antibodies (p < 0.0001).…”
Section: Hla Antibodies and Scd30 In Renal Transplantationmentioning
confidence: 96%
“…In the present study, we have directly compared two solid phase assays for the detection of antibodies. Previous reports have suggested the Luminex assay detects HSA more frequently than the ELISA assay (34,35). We have shown that both class I and class II antibodies are detected more frequently by Luminex, although the difference in frequency was only significant for class I antibodies (p < 0.0001).…”
Section: Hla Antibodies and Scd30 In Renal Transplantationmentioning
confidence: 96%
“…We found, as others have, that the bead assays are more sensitive than either ELISA with soluble HLA targets or flow cytometric crossmatches with lymphocyte targets [11][12][13]. We used the Luminex assays to evaluate of a large cohort of patients undergoing treatment with plasmapheresis and CMVIg to eliminate DSA.…”
Section: Introductionmentioning
confidence: 99%
“…Considerable data confirm the advantage of the multiplexed technology and its applications in diverse fields of medicine, including cancer research, cytokines, gene expression, and genetic and infectious diseases. [9][10][11][12][13][14] An application of multiplexed technology in the field of autoimmunity suggests that this assay may be suitable as a sensitive screening method for detection of numerous autoantibodies in patients with autoimmune diseases. [15][16][17][18] It has been demonstrated that multiplexed technology offers a useful tool for the detection of ANA and extractable nuclear antigens in autoimmune diseases.…”
Section: Introductionmentioning
confidence: 99%